Home > > > > > Report Detail

Global Liraglutide Market Growth 2023-2029

Publisher Name :
Date: 04-Jan-2023
No. of pages: 90

Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.

LPI (LP Information)' newest research report, the "Liraglutide Industry Forecast" looks at past sales and reviews total world Liraglutide sales in 2022, providing a comprehensive analysis by region and market sector of projected Liraglutide sales for 2023 through 2029. With Liraglutide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Liraglutide industry.

This Insight Report provides a comprehensive analysis of the global Liraglutide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Liraglutide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Liraglutide market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Liraglutide and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Liraglutide.

The global Liraglutide market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Liraglutide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Liraglutide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Liraglutide is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Liraglutide players cover HEC Pharm, Bachem, Bharat Pharmaceuticals, Kingpep Biotechnology, Shenzhen JYMed Technology, Wuxi Asiapeptide and AmbioPharm, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Liraglutide market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

- Pills

- Liquid

Segmentation by application

- Hospital

- Drug Store

The below companies that are profiled

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

- HEC Pharm

- Bachem

- Bharat Pharmaceuticals

- Kingpep Biotechnology

- Shenzhen JYMed Technology

- Wuxi Asiapeptide

- AmbioPharm

Key Questions Addressed in this Report

What is the 10-year outlook for the global Liraglutide market?

What factors are driving Liraglutide market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Liraglutide market opportunities vary by end market size?

How does Liraglutide break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Global Liraglutide Market Growth 2023-2029

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Liraglutide Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Liraglutide by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Liraglutide by Country/Region, 2018, 2022 & 2029
2.2 Liraglutide Segment by Type
2.2.1 Pills
2.2.2 Liquid
2.3 Liraglutide Sales by Type
2.3.1 Global Liraglutide Sales Market Share by Type (2018-2023)
2.3.2 Global Liraglutide Revenue and Market Share by Type (2018-2023)
2.3.3 Global Liraglutide Sale Price by Type (2018-2023)
2.4 Liraglutide Segment by Application
2.4.1 Hospital
2.4.2 Drug Store
2.5 Liraglutide Sales by Application
2.5.1 Global Liraglutide Sale Market Share by Application (2018-2023)
2.5.2 Global Liraglutide Revenue and Market Share by Application (2018-2023)
2.5.3 Global Liraglutide Sale Price by Application (2018-2023)
3 Global Liraglutide by Company
3.1 Global Liraglutide Breakdown Data by Company
3.1.1 Global Liraglutide Annual Sales by Company (2018-2023)
3.1.2 Global Liraglutide Sales Market Share by Company (2018-2023)
3.2 Global Liraglutide Annual Revenue by Company (2018-2023)
3.2.1 Global Liraglutide Revenue by Company (2018-2023)
3.2.2 Global Liraglutide Revenue Market Share by Company (2018-2023)
3.3 Global Liraglutide Sale Price by Company
3.4 Key Manufacturers Liraglutide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Liraglutide Product Location Distribution
3.4.2 Players Liraglutide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Liraglutide by Geographic Region
4.1 World Historic Liraglutide Market Size by Geographic Region (2018-2023)
4.1.1 Global Liraglutide Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Liraglutide Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Liraglutide Market Size by Country/Region (2018-2023)
4.2.1 Global Liraglutide Annual Sales by Country/Region (2018-2023)
4.2.2 Global Liraglutide Annual Revenue by Country/Region (2018-2023)
4.3 Americas Liraglutide Sales Growth
4.4 APAC Liraglutide Sales Growth
4.5 Europe Liraglutide Sales Growth
4.6 Middle East & Africa Liraglutide Sales Growth
5 Americas
5.1 Americas Liraglutide Sales by Country
5.1.1 Americas Liraglutide Sales by Country (2018-2023)
5.1.2 Americas Liraglutide Revenue by Country (2018-2023)
5.2 Americas Liraglutide Sales by Type
5.3 Americas Liraglutide Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Liraglutide Sales by Region
6.1.1 APAC Liraglutide Sales by Region (2018-2023)
6.1.2 APAC Liraglutide Revenue by Region (2018-2023)
6.2 APAC Liraglutide Sales by Type
6.3 APAC Liraglutide Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Liraglutide by Country
7.1.1 Europe Liraglutide Sales by Country (2018-2023)
7.1.2 Europe Liraglutide Revenue by Country (2018-2023)
7.2 Europe Liraglutide Sales by Type
7.3 Europe Liraglutide Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Liraglutide by Country
8.1.1 Middle East & Africa Liraglutide Sales by Country (2018-2023)
8.1.2 Middle East & Africa Liraglutide Revenue by Country (2018-2023)
8.2 Middle East & Africa Liraglutide Sales by Type
8.3 Middle East & Africa Liraglutide Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Liraglutide
10.3 Manufacturing Process Analysis of Liraglutide
10.4 Industry Chain Structure of Liraglutide
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Liraglutide Distributors
11.3 Liraglutide Customer
12 World Forecast Review for Liraglutide by Geographic Region
12.1 Global Liraglutide Market Size Forecast by Region
12.1.1 Global Liraglutide Forecast by Region (2024-2029)
12.1.2 Global Liraglutide Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Liraglutide Forecast by Type
12.7 Global Liraglutide Forecast by Application
13 Key Players Analysis
13.1 HEC Pharm
13.1.1 HEC Pharm Company Information
13.1.2 HEC Pharm Liraglutide Product Portfolios and Specifications
13.1.3 HEC Pharm Liraglutide Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 HEC Pharm Main Business Overview
13.1.5 HEC Pharm Latest Developments
13.2 Bachem
13.2.1 Bachem Company Information
13.2.2 Bachem Liraglutide Product Portfolios and Specifications
13.2.3 Bachem Liraglutide Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Bachem Main Business Overview
13.2.5 Bachem Latest Developments
13.3 Bharat Pharmaceuticals
13.3.1 Bharat Pharmaceuticals Company Information
13.3.2 Bharat Pharmaceuticals Liraglutide Product Portfolios and Specifications
13.3.3 Bharat Pharmaceuticals Liraglutide Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Bharat Pharmaceuticals Main Business Overview
13.3.5 Bharat Pharmaceuticals Latest Developments
13.4 Kingpep Biotechnology
13.4.1 Kingpep Biotechnology Company Information
13.4.2 Kingpep Biotechnology Liraglutide Product Portfolios and Specifications
13.4.3 Kingpep Biotechnology Liraglutide Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Kingpep Biotechnology Main Business Overview
13.4.5 Kingpep Biotechnology Latest Developments
13.5 Shenzhen JYMed Technology
13.5.1 Shenzhen JYMed Technology Company Information
13.5.2 Shenzhen JYMed Technology Liraglutide Product Portfolios and Specifications
13.5.3 Shenzhen JYMed Technology Liraglutide Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Shenzhen JYMed Technology Main Business Overview
13.5.5 Shenzhen JYMed Technology Latest Developments
13.6 Wuxi Asiapeptide
13.6.1 Wuxi Asiapeptide Company Information
13.6.2 Wuxi Asiapeptide Liraglutide Product Portfolios and Specifications
13.6.3 Wuxi Asiapeptide Liraglutide Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Wuxi Asiapeptide Main Business Overview
13.6.5 Wuxi Asiapeptide Latest Developments
13.7 AmbioPharm
13.7.1 AmbioPharm Company Information
13.7.2 AmbioPharm Liraglutide Product Portfolios and Specifications
13.7.3 AmbioPharm Liraglutide Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 AmbioPharm Main Business Overview
13.7.5 AmbioPharm Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Liraglutide Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Liraglutide Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Pills
Table 4. Major Players of Liquid
Table 5. Global Liraglutide Sales by Type (2018-2023) & (K MT)
Table 6. Global Liraglutide Sales Market Share by Type (2018-2023)
Table 7. Global Liraglutide Revenue by Type (2018-2023) & ($ million)
Table 8. Global Liraglutide Revenue Market Share by Type (2018-2023)
Table 9. Global Liraglutide Sale Price by Type (2018-2023) & (USD/MT)
Table 10. Global Liraglutide Sales by Application (2018-2023) & (K MT)
Table 11. Global Liraglutide Sales Market Share by Application (2018-2023)
Table 12. Global Liraglutide Revenue by Application (2018-2023)
Table 13. Global Liraglutide Revenue Market Share by Application (2018-2023)
Table 14. Global Liraglutide Sale Price by Application (2018-2023) & (USD/MT)
Table 15. Global Liraglutide Sales by Company (2018-2023) & (K MT)
Table 16. Global Liraglutide Sales Market Share by Company (2018-2023)
Table 17. Global Liraglutide Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Liraglutide Revenue Market Share by Company (2018-2023)
Table 19. Global Liraglutide Sale Price by Company (2018-2023) & (USD/MT)
Table 20. Key Manufacturers Liraglutide Producing Area Distribution and Sales Area
Table 21. Players Liraglutide Products Offered
Table 22. Liraglutide Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Liraglutide Sales by Geographic Region (2018-2023) & (K MT)
Table 26. Global Liraglutide Sales Market Share Geographic Region (2018-2023)
Table 27. Global Liraglutide Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Liraglutide Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Liraglutide Sales by Country/Region (2018-2023) & (K MT)
Table 30. Global Liraglutide Sales Market Share by Country/Region (2018-2023)
Table 31. Global Liraglutide Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Liraglutide Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Liraglutide Sales by Country (2018-2023) & (K MT)
Table 34. Americas Liraglutide Sales Market Share by Country (2018-2023)
Table 35. Americas Liraglutide Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Liraglutide Revenue Market Share by Country (2018-2023)
Table 37. Americas Liraglutide Sales by Type (2018-2023) & (K MT)
Table 38. Americas Liraglutide Sales by Application (2018-2023) & (K MT)
Table 39. APAC Liraglutide Sales by Region (2018-2023) & (K MT)
Table 40. APAC Liraglutide Sales Market Share by Region (2018-2023)
Table 41. APAC Liraglutide Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Liraglutide Revenue Market Share by Region (2018-2023)
Table 43. APAC Liraglutide Sales by Type (2018-2023) & (K MT)
Table 44. APAC Liraglutide Sales by Application (2018-2023) & (K MT)
Table 45. Europe Liraglutide Sales by Country (2018-2023) & (K MT)
Table 46. Europe Liraglutide Sales Market Share by Country (2018-2023)
Table 47. Europe Liraglutide Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Liraglutide Revenue Market Share by Country (2018-2023)
Table 49. Europe Liraglutide Sales by Type (2018-2023) & (K MT)
Table 50. Europe Liraglutide Sales by Application (2018-2023) & (K MT)
Table 51. Middle East & Africa Liraglutide Sales by Country (2018-2023) & (K MT)
Table 52. Middle East & Africa Liraglutide Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Liraglutide Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Liraglutide Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Liraglutide Sales by Type (2018-2023) & (K MT)
Table 56. Middle East & Africa Liraglutide Sales by Application (2018-2023) & (K MT)
Table 57. Key Market Drivers & Growth Opportunities of Liraglutide
Table 58. Key Market Challenges & Risks of Liraglutide
Table 59. Key Industry Trends of Liraglutide
Table 60. Liraglutide Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Liraglutide Distributors List
Table 63. Liraglutide Customer List
Table 64. Global Liraglutide Sales Forecast by Region (2024-2029) & (K MT)
Table 65. Global Liraglutide Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Liraglutide Sales Forecast by Country (2024-2029) & (K MT)
Table 67. Americas Liraglutide Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Liraglutide Sales Forecast by Region (2024-2029) & (K MT)
Table 69. APAC Liraglutide Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Liraglutide Sales Forecast by Country (2024-2029) & (K MT)
Table 71. Europe Liraglutide Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Liraglutide Sales Forecast by Country (2024-2029) & (K MT)
Table 73. Middle East & Africa Liraglutide Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Liraglutide Sales Forecast by Type (2024-2029) & (K MT)
Table 75. Global Liraglutide Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Liraglutide Sales Forecast by Application (2024-2029) & (K MT)
Table 77. Global Liraglutide Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. HEC Pharm Basic Information, Liraglutide Manufacturing Base, Sales Area and Its Competitors
Table 79. HEC Pharm Liraglutide Product Portfolios and Specifications
Table 80. HEC Pharm Liraglutide Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 81. HEC Pharm Main Business
Table 82. HEC Pharm Latest Developments
Table 83. Bachem Basic Information, Liraglutide Manufacturing Base, Sales Area and Its Competitors
Table 84. Bachem Liraglutide Product Portfolios and Specifications
Table 85. Bachem Liraglutide Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 86. Bachem Main Business
Table 87. Bachem Latest Developments
Table 88. Bharat Pharmaceuticals Basic Information, Liraglutide Manufacturing Base, Sales Area and Its Competitors
Table 89. Bharat Pharmaceuticals Liraglutide Product Portfolios and Specifications
Table 90. Bharat Pharmaceuticals Liraglutide Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 91. Bharat Pharmaceuticals Main Business
Table 92. Bharat Pharmaceuticals Latest Developments
Table 93. Kingpep Biotechnology Basic Information, Liraglutide Manufacturing Base, Sales Area and Its Competitors
Table 94. Kingpep Biotechnology Liraglutide Product Portfolios and Specifications
Table 95. Kingpep Biotechnology Liraglutide Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 96. Kingpep Biotechnology Main Business
Table 97. Kingpep Biotechnology Latest Developments
Table 98. Shenzhen JYMed Technology Basic Information, Liraglutide Manufacturing Base, Sales Area and Its Competitors
Table 99. Shenzhen JYMed Technology Liraglutide Product Portfolios and Specifications
Table 100. Shenzhen JYMed Technology Liraglutide Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 101. Shenzhen JYMed Technology Main Business
Table 102. Shenzhen JYMed Technology Latest Developments
Table 103. Wuxi Asiapeptide Basic Information, Liraglutide Manufacturing Base, Sales Area and Its Competitors
Table 104. Wuxi Asiapeptide Liraglutide Product Portfolios and Specifications
Table 105. Wuxi Asiapeptide Liraglutide Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 106. Wuxi Asiapeptide Main Business
Table 107. Wuxi Asiapeptide Latest Developments
Table 108. AmbioPharm Basic Information, Liraglutide Manufacturing Base, Sales Area and Its Competitors
Table 109. AmbioPharm Liraglutide Product Portfolios and Specifications
Table 110. AmbioPharm Liraglutide Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 111. AmbioPharm Main Business
Table 112. AmbioPharm Latest Developments
List of Figures
Figure 1. Picture of Liraglutide
Figure 2. Liraglutide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Liraglutide Sales Growth Rate 2018-2029 (K MT)
Figure 7. Global Liraglutide Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Liraglutide Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Pills
Figure 10. Product Picture of Liquid
Figure 11. Global Liraglutide Sales Market Share by Type in 2022
Figure 12. Global Liraglutide Revenue Market Share by Type (2018-2023)
Figure 13. Liraglutide Consumed in Hospital
Figure 14. Global Liraglutide Market: Hospital (2018-2023) & (K MT)
Figure 15. Liraglutide Consumed in Drug Store
Figure 16. Global Liraglutide Market: Drug Store (2018-2023) & (K MT)
Figure 17. Global Liraglutide Sales Market Share by Application (2022)
Figure 18. Global Liraglutide Revenue Market Share by Application in 2022
Figure 19. Liraglutide Sales Market by Company in 2022 (K MT)
Figure 20. Global Liraglutide Sales Market Share by Company in 2022
Figure 21. Liraglutide Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Liraglutide Revenue Market Share by Company in 2022
Figure 23. Global Liraglutide Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Liraglutide Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Liraglutide Sales 2018-2023 (K MT)
Figure 26. Americas Liraglutide Revenue 2018-2023 ($ Millions)
Figure 27. APAC Liraglutide Sales 2018-2023 (K MT)
Figure 28. APAC Liraglutide Revenue 2018-2023 ($ Millions)
Figure 29. Europe Liraglutide Sales 2018-2023 (K MT)
Figure 30. Europe Liraglutide Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Liraglutide Sales 2018-2023 (K MT)
Figure 32. Middle East & Africa Liraglutide Revenue 2018-2023 ($ Millions)
Figure 33. Americas Liraglutide Sales Market Share by Country in 2022
Figure 34. Americas Liraglutide Revenue Market Share by Country in 2022
Figure 35. Americas Liraglutide Sales Market Share by Type (2018-2023)
Figure 36. Americas Liraglutide Sales Market Share by Application (2018-2023)
Figure 37. United States Liraglutide Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Liraglutide Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Liraglutide Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Liraglutide Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Liraglutide Sales Market Share by Region in 2022
Figure 42. APAC Liraglutide Revenue Market Share by Regions in 2022
Figure 43. APAC Liraglutide Sales Market Share by Type (2018-2023)
Figure 44. APAC Liraglutide Sales Market Share by Application (2018-2023)
Figure 45. China Liraglutide Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Liraglutide Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Liraglutide Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Liraglutide Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Liraglutide Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Liraglutide Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Liraglutide Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Liraglutide Sales Market Share by Country in 2022
Figure 53. Europe Liraglutide Revenue Market Share by Country in 2022
Figure 54. Europe Liraglutide Sales Market Share by Type (2018-2023)
Figure 55. Europe Liraglutide Sales Market Share by Application (2018-2023)
Figure 56. Germany Liraglutide Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Liraglutide Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Liraglutide Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Liraglutide Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Liraglutide Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Liraglutide Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Liraglutide Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Liraglutide Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Liraglutide Sales Market Share by Application (2018-2023)
Figure 65. Egypt Liraglutide Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Liraglutide Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Liraglutide Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Liraglutide Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Liraglutide Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Liraglutide in 2022
Figure 71. Manufacturing Process Analysis of Liraglutide
Figure 72. Industry Chain Structure of Liraglutide
Figure 73. Channels of Distribution
Figure 74. Global Liraglutide Sales Market Forecast by Region (2024-2029)
Figure 75. Global Liraglutide Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Liraglutide Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Liraglutide Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Liraglutide Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Liraglutide Revenue Market Share Forecast by Application (2024-2029)
  • Global Metformin Hydrochloride Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Metformin hydrochloride is a white to off-white crystall......
  • Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Antidiabetic Sulphonylureas market: According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......
  • Global Insulin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......
  • Global Insulin API Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period. The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • Global Glucagon Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period. The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Acarbose Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period. The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Insulin Glargine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 77
    According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period. The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......
  • Global Liraglutide Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 103
    According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......
  • Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period. The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs